Glycogen synthase kinase-3β and cathepsin B in diabetic endothelial progenitor cell dysfunction: an old player finds a new partner.
作者信息
Muniyappa Ranganath, Sowers James R
机构信息
Clinical Endocrine Section, Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
出版信息
Diabetes. 2014 Apr;63(4):1194-7. doi: 10.2337/db14-0004.
Abstract
摘要
相似文献
1
Glycogen synthase kinase-3β and cathepsin B in diabetic endothelial progenitor cell dysfunction: an old player finds a new partner.
Diabetes. 2014 Apr;63(4):1194-7. doi: 10.2337/db14-0004.
2
Glycogen synthase kinase-3β inhibition augments diabetic endothelial progenitor cell abundance and functionality via cathepsin B: a novel therapeutic opportunity for arterial repair.
Diabetes. 2014 Apr;63(4):1410-21. doi: 10.2337/db13-0941. Epub 2013 Dec 2.
3
Glycogen synthase kinase 3β inhibition enhanced proliferation, migration and functional re-endothelialization of endothelial progenitor cells in hypercholesterolemia microenvironment.
Exp Biol Med (Maywood). 2015 Dec;240(12):1752-63. doi: 10.1177/1535370215589908. Epub 2015 Jun 10.
4
Glycogen synthase kinase-3beta inhibition attenuates asthma in mice.
Am J Respir Crit Care Med. 2007 Sep 1;176(5):431-8. doi: 10.1164/rccm.200609-1292OC. Epub 2007 Jun 7.
5
Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
Pharmacol Res. 2015 Jul;97:16-26. doi: 10.1016/j.phrs.2015.03.010. Epub 2015 Mar 28.
6
Inhibiting glycogen synthase kinase 3beta in sepsis.
Novartis Found Symp. 2007;280:128-42; discussion 142-6, 160-4.
7
The role of glycogen synthase kinase-3beta in schizophrenia.
Drug News Perspect. 2007 Sep;20(7):437-45. doi: 10.1358/dnp.2007.20.7.1149632.
8
Adiponectin stimulates proliferation of adult hippocampal neural stem/progenitor cells through activation of p38 mitogen-activated protein kinase (p38MAPK)/glycogen synthase kinase 3β (GSK-3β)/β-catenin signaling cascade.
J Biol Chem. 2011 Dec 30;286(52):44913-20. doi: 10.1074/jbc.M111.310052. Epub 2011 Oct 28.
9
Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor.
Cardiovasc Res. 2010 May 1;86(2):338-45. doi: 10.1093/cvr/cvq047. Epub 2010 Feb 17.
10
Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation.
Shock. 2007 Feb;27(2):113-23. doi: 10.1097/01.shk.0000238059.23837.68.
引用本文的文献
1
AGEs Inducing EPCs Apoptosis via ROS and p38 MAPK/JNK Pathways in Diabetic Vascular Complications.
Physiol Res. 2025 Aug 31;74(4):601-611. doi: 10.33549/physiolres.935554.
2
Cathepsin B induces kidney diseases through different types of programmed cell death.
Front Immunol. 2025 Mar 10;16:1535313. doi: 10.3389/fimmu.2025.1535313. eCollection 2025.
3
CircRNA-miRNA interactions in atherogenesis.
Mol Cell Biochem. 2022 Dec;477(12):2703-2733. doi: 10.1007/s11010-022-04455-8. Epub 2022 May 23.
4
Circ-ADAM9 targeting PTEN and ATG7 promotes autophagy and apoptosis of diabetic endothelial progenitor cells by sponging mir-20a-5p.
Cell Death Dis. 2020 Jul 13;11(7):526. doi: 10.1038/s41419-020-02745-x.
5
BODIPY-Caged Photoactivated Inhibitors of Cathepsin B Flip the Light Switch on Cancer Cell Apoptosis.
ACS Chem Biol. 2019 Dec 20;14(12):2833-2840. doi: 10.1021/acschembio.9b00711. Epub 2019 Dec 6.
6
Ginsenoside Rg5 Inhibits Succinate-Associated Lipolysis in Adipose Tissue and Prevents Muscle Insulin Resistance.
Front Pharmacol. 2017 Feb 14;8:43. doi: 10.3389/fphar.2017.00043. eCollection 2017.
7
Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality.
Stem Cells Int. 2017;2017:8270498. doi: 10.1155/2017/8270498. Epub 2017 Jan 23.
8
Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia.
Circ Res. 2017 Mar 3;120(5):e7-e23. doi: 10.1161/CIRCRESAHA.117.310619. Epub 2017 Jan 30.
本文引用的文献
1
Lithium chloride enhances cathepsin H expression and BMP-4 degradation in C3H10T1/2 cells.
Biomed Res Int. 2013;2013:143742. doi: 10.1155/2013/143742. Epub 2013 Nov 10.
2
Glycogen synthase kinase-3β inhibition augments diabetic endothelial progenitor cell abundance and functionality via cathepsin B: a novel therapeutic opportunity for arterial repair.
Diabetes. 2014 Apr;63(4):1410-21. doi: 10.2337/db13-0941. Epub 2013 Dec 2.
3
Postischemic revascularization: from cellular and molecular mechanisms to clinical applications.
Physiol Rev. 2013 Oct;93(4):1743-802. doi: 10.1152/physrev.00006.2013.
4
Cell therapy of peripheral arterial disease: from experimental findings to clinical trials.
Circ Res. 2013 Apr 26;112(9):1288-302. doi: 10.1161/CIRCRESAHA.113.300565.
5
Inhibition of lysosomal function in macrophages incubated with elevated glucose concentrations: a potential contributory factor in diabetes-associated atherosclerosis.
Atherosclerosis. 2012 Jul;223(1):144-51. doi: 10.1016/j.atherosclerosis.2012.04.026. Epub 2012 May 11.
6
Nuclear translocation of β-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype.
PLoS One. 2012;7(4):e34656. doi: 10.1371/journal.pone.0034656. Epub 2012 Apr 10.
7
Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence.
Am J Pathol. 2012 Mar;180(3):973-983. doi: 10.1016/j.ajpath.2011.11.033. Epub 2012 Jan 9.
8
Concise review: Circulating endothelial progenitor cells for vascular medicine.
Stem Cells. 2011 Nov;29(11):1650-5. doi: 10.1002/stem.745.
9
Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges.
Eur Heart J. 2011 May;32(10):1197-206. doi: 10.1093/eurheartj/ehr018. Epub 2011 Feb 28.
10
Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance.
Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1088-93. doi: 10.1161/ATVBAHA.109.191668. Epub 2010 May 7.
Zotero 插件